{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:25:57Z","timestamp":1788387957853,"version":"build-2803163510"},"reference-count":24,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1699,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1600-0404.2010.01472.x","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T07:38:17Z","timestamp":1294299497000},"page":"22-27","source":"Crossref","is-referenced-by-count":18,"title":["Outcome of lamotrigine treatment in juvenile myoclonic epilepsy"],"prefix":"10.1155","volume":"124","author":[{"given":"H.","family":"Bodenstein-Sachar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gandelman-Marton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ben-Zeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Blatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2011,1,6]]},"reference":[{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1600-0404.2006.00791.x","article-title":"Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting","volume":"115","author":"Mohanraj","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/pmj.79.928.78","article-title":"Juvenile myoclonic epilepsy: under-appreciated and under-diagnosed","volume":"79","author":"Renganathan","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB3|cit3","first-page":"389","article-title":"Proposal for revised international classification of epilepsies, epileptic syndromes and related seizure disorders","volume":"4","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1989","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB4|cit4","first-page":"115","article-title":"Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy","volume":"122","author":"Jayalakshmi","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1059-1311(00)90530-2","article-title":"Evolution of JME treated from the outset with sodium valproate","volume":"10","author":"Calleja","year":"2001","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine or topiramate for generalized and unclassifiable epilepsy: an unblinded randomized controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/seiz.2001.0662","article-title":"Clinical expression and EEG features of patients with JME from North India","volume":"11","author":"Mehndiratta","year":"2002","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jnnp.70.2.240","article-title":"Clinical factors of drug resistance in JME","volume":"70","author":"Gelisse","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/archneur.60.8.1100","article-title":"Evolving antiepileptic drug treatment in JME","volume":"60","author":"Prasad","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB10|cit10","first-page":"369","volume-title":"Handbook of clinical neurology, vol. 73 (29): the epilepsies, part two","author":"Gram","year":"2000"},{"issue":"Suppl. 5","key":"10.1111\/j.1600-0404.2010.01472.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1528-1157.1998.tb05141.x","article-title":"Role of new and established antiepileptic drugs","volume":"39","author":"Leppik","year":"1998","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.yebeh.2004.04.002","article-title":"Lamotrigine for patients with JME following prior treatment with valproate: results of an open-label study","volume":"5","author":"Morris","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1059-1311(96)80110-5","article-title":"The use of lamotrigine in juvenile myoclonic epilepsy","volume":"2","author":"Buchanan","year":"1996","journal-title":"Seziure"},{"issue":"Suppl. 1","key":"10.1111\/j.1600-0404.2010.01472.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2005.06.001","article-title":"Treatment of epilepsy in adults: expert opinion, 2005","volume":"7","author":"Karceski","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1684\/epd.2007.0144","article-title":"Treatment of pediatric epilepsy: European expert opinion, 2007","volume":"9","author":"Wheless","year":"2007","journal-title":"Epileptic Disord"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB16|cit16","first-page":"1","article-title":"Malformation risks of anti-epileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"10","author":"Morrow","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1034\/j.1600-0404.2003.00200.x","article-title":"Epilepsy and pregnancy: lamotrigine as main drug used","volume":"109","author":"Sabers","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1212\/01.WNL.0000154515.94346.89","article-title":"Lamotrigine and the risk of malformations in pregnancy","volume":"64","author":"Cunnington","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.seizure.2010.01.014","article-title":"Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents","volume":"19","author":"Mazurkiewicz-Beldzinska","year":"2010","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB20|cit20","first-page":"75","article-title":"The relationship between treatment with valproate, lamotrigine and topiramate and the prognosis of the idiopathic generalised epilepsies","volume":"75","author":"Nicolson","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/seiz.2000.0432","article-title":"Characteristics of valproic acid resistant JME","volume":"9","author":"Fernando-Dongas","year":"2000","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1059-1311(05)80097-4","article-title":"Characterization of intractable JME: new perspectives on primarily generalized seizures-Abstract","volume":"2","author":"Dasheiff","year":"1993","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1046\/j.1528-1157.2001.02101.x","article-title":"A pharmacoepidemiologic study of factors of influencing the outcome of treatment with lamotrigine in chronic epilepsy","volume":"42","author":"Wong","year":"2001","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2010.01472.x-BIB24|cit24","first-page":"293","article-title":"The seizure prognosis of JME","volume":"46","author":"Matsuoka","year":"1992","journal-title":"Jpn J Psychiatry Neurol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2010.01472.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2010.01472.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T19:38:57Z","timestamp":1712086737000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2010.01472.x"}},"subtitle":["Outcome of LTG treatment in JME"],"short-title":[],"issued":{"date-parts":[[2011,1,6]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2010.01472.x","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,6]]}}}